Abstract

BackgroundAn Individual Patient Data (IPD) meta-analysis is often considered the gold-standard for synthesising survival data from clinical trials. An IPD meta-analysis can be achieved by either a two-stage or a one-stage approach, depending on whether the trials are analysed separately or simultaneously. A range of one-stage hierarchical Cox models have been previously proposed, but these are known to be computationally intensive and are not currently available in all standard statistical software. We describe an alternative approach using Poisson based Generalised Linear Models (GLMs).MethodsWe illustrate, through application and simulation, the Poisson approach both classically and in a Bayesian framework, in two-stage and one-stage approaches. We outline the benefits of our one-stage approach through extension to modelling treatment-covariate interactions and non-proportional hazards. Ten trials of hypertension treatment, with all-cause death the outcome of interest, are used to apply and assess the approach.ResultsWe show that the Poisson approach obtains almost identical estimates to the Cox model, is additionally computationally efficient and directly estimates the baseline hazard. Some downward bias is observed in classical estimates of the heterogeneity in the treatment effect, with improved performance from the Bayesian approach.ConclusionOur approach provides a highly flexible and computationally efficient framework, available in all standard statistical software, to the investigation of not only heterogeneity, but the presence of non-proportional hazards and treatment effect modifiers.

Highlights

  • An Individual Patient Data (IPD) meta-analysis is often considered the gold-standard for synthesising survival data from clinical trials

  • An approach often considered the gold-standard alternative to an aggregate data (AD) meta-analysis is a meta-analysis of individual patient data (IPD), which utilises the raw data from each study

  • The aim of this paper is to explore the use of Poisson regression, and the generalised mixed model extensions, to incorporate random effects to perform one- and twostage IPD meta-analyses of time-to-event outcomes, as an alternative to hierarchical Cox models, and to extend the models to incorporate non-proportional hazards and treatment-effect modifiers

Read more

Summary

Introduction

An Individual Patient Data (IPD) meta-analysis is often considered the gold-standard for synthesising survival data from clinical trials. The use of AD to conduct a metaanalysis has inherent problems, for example, hazard ratios are not always explicitly given in publications, An approach often considered the gold-standard alternative to an AD meta-analysis is a meta-analysis of individual patient data (IPD), which utilises the raw data from each study. The benefits of conducting an IPD meta-analysis with time-to-event data include: follow-up time can be longer and more up to date, analyses can be standardised across studies, model assumptions can be checked e.g. proportional hazards, and confounders can be adjusted for. An early proposal by Dear [7] showed how to jointly synthesise survival proportions reported at multiple times, by utilising their correlation and combining them in a multivariate meta-analysis using generalised least squares. Further extensions of AD metaanalyses include assessment of the proportional hazards assumption [9,11]

Objectives
Methods
Results
Discussion
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.